Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and

Bhurint Siripanthong1, Saman Nazarian2, Daniele Muser2

  • 1School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.

Heart Rhythm
|May 11, 2020
PubMed

Insights

COVID-19 myocarditis involves direct viral injury and immune response. Diagnosis uses clinical findings, imaging, and possibly biopsy, requiring vigilant monitoring for arrhythmias and long-term effects.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pathophysiology

Background:

  • Myocarditis associated with human coronaviruses, including COVID-19, is recognized.
  • COVID-19 myocarditis pathophysiology likely involves direct viral effects and immune-mediated cardiac damage.

Purpose of the Study:

  • To outline diagnostic approaches for COVID-19 myocarditis.
  • To highlight clinical findings, imaging techniques, and potential diagnostic uncertainties.

Main Methods:

  • Review of clinical findings: electrocardiogram changes, cardiac biomarkers, and impaired cardiac function.
  • Evaluation of imaging modalities: cardiac MRI and computed tomographic angiography with delayed myocardial imaging.
  • Consideration of endomyocardial biopsy for definitive diagnosis and treatment guidance.

Main Results:

  • Clinical presentation includes ECG changes, elevated cardiac biomarkers, and reduced cardiac function.
  • Cardiac CT angiography can help rule out coronary artery disease and detect myocardial inflammation.
  • Endomyocardial biopsy may confirm active cardiac infection and inform immunosuppression risks.

Conclusions:

  • Diagnosis of COVID-19 myocarditis requires integrating prior myocarditis knowledge with current clinical and imaging data.
  • Vigilance for arrhythmias and consideration of myocardial infarction in patients with cardiovascular comorbidities are crucial.
  • The long-term sequelae of COVID-19 myocarditis remain largely unknown.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
116
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
156
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
180
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
273
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219